MONEO: Phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC)

by on 30 d'octubre de 2023 with No hi ha comentaris
  • Alsina, M., Ponz-Sarvise, M., Garcia, D. L., Villacampa, G., De Andrea, C., Ochoa, C., . . . Tabernero, A., Melero, I. (2023). MONEO: Phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC). Annals of Oncology, 34, S2-S3. https://doi.org/10.1016/j.annonc.2023.04.032

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *